STAAR SURGICAL CO·4

Jun 22, 4:05 PM ET

Zhou Lilian Yansheng 4

Research Summary

AI-generated summary

Updated

STAA Director Zhou Lilian Yansheng Receives Equity Award

What Happened

  • Director Zhou Lilian Yansheng received grants on June 18, 2026 consisting of 3,091 restricted stock units and 5,572 stock option awards (total = 8,663). The Form 4 reports these as derivative awards at $0.00 per share (typical for RSU/option grants; not a cash purchase or sale).

Key Details

  • Transaction date: June 18, 2026; Form 4 filed: June 22, 2026 (filed four days after the grant).
  • Reported amounts/prices: 3,091 RSUs @ $0.00 and 5,572 options @ $0.00 (total 8,663 awards).
  • Shares owned after transaction: not disclosed in the filing.
  • Footnote: F1 states these are restricted stock units and options granted under the issuer’s annual non-employee director equity program for the 2026–2027 term; they vest in full on the earlier of June 18, 2027 or the issuer’s 2027 Annual Meeting of Shareholders.
  • Timeliness: Filing occurred four days after the grant date, which is later than the typical two-business-day Form 4 deadline.

Context

  • These awards are compensation for director service, not an open-market purchase or sale. RSUs convert to shares upon vesting; options give the right to buy shares later (exercise required to obtain shares).
  • Because this is an equity award, it does not signal an immediate sale or purchase by the director and should be viewed as standard director compensation unless further trading follows.